Open AccessS167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B
Author(s) -
Tobiasson M.,
Pandzic T.,
Illman J.,
Nilsson L.,
Weström S.,
Sollander K.,
Ejerblad E.,
Olsnes Kittang A.,
Olesen G.,
Werlenius O.,
Björklund A.,
Wiggh J.,
lindholm C.,
Lorentz F.,
Rasmussen B.,
Cammenga J.,
Weber D.,
Grönnås D.,
Dimitriou M.,
Kytölä S.,
Walldin G.,
Ljungman P.,
Groenbeck K.,
Mielke S.,
Jacobsen S. E.,
Ebeling F.,
Cavelier L.,
Smidstrup Friis L.,
Dybedal I.,
HellströmLindberg E.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843560.87168.a9
Subject(s) - medicine , minimal residual disease , transplantation , oncology , prospective cohort study , bone marrow , myeloid